Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein light chain LC8-type 1 pseudogene 7 (DYNLL1P7) is annotated as a **processed pseudogene** in the human genome[1]. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically lack the ability to encode a protein product due to mutations, truncations, or the absence of regulatory features[2]. DYNLL1P7 is related in sequence to the DYNLL1 gene, which encodes a dynein light chain involved in microtubule-based transport and various protein complexes[3][5]; however, as a pseudogene, DYNLL1P7 does not produce a functional protein and does not have known biological activity or involvement in disease, drug targeting, or cellular pathways[1].\nSome processed pseudogenes can, in rare cases, have regulatory roles at the RNA level (for example, acting as RNA decoys), but there is no evidence that DYNLL1P7 has such a function[2][1].\nDYNLL1P7 should not be confused with the protein-coding gene DYNLL1 (Dynein light chain LC8-type 1), which does have known roles in cellular transport and disease[3][5].\n\n**Key clarifications:**\n- DYNLL1P7 is **not a protein-coding gene** and **not a therapeutic target**.\n- The entry is **not suitable as a drug target**; listings of mechanisms, ligands, or biomarkers are not applicable.\n- The name is **correct** for this pseudogene, but if a *functional* dynein light chain is the intended target, DYNLL1 (not DYNLL1P7) would be appropriate[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein light chain LC8-type 1 pseudogene 7 (DYNLL1P7).